<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="569">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04599998</url>
  </required_header>
  <id_info>
    <org_study_id>2020.188.IRB1.056</org_study_id>
    <nct_id>NCT04599998</nct_id>
  </id_info>
  <brief_title>Long-term Follow-up Findings of Inpatients for COVID-19 Pneumonia</brief_title>
  <official_title>Long-term Follow-up Findings of Inpatients for COVID-19 Pneumonia Related to Lung Functions, Radiology and Exercise Capacity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Koc University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Koc University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly&#xD;
      emergent coronavirus (SARS-CoV-2) that can progress to severe multiorgan disease requiring&#xD;
      hospitalization. The medium and long-term impact in survivors of COVID-19 on lung function,&#xD;
      imaging by thoracic CT, exercise capacity, and health-related quality of life and the&#xD;
      relation of these parameters remains to be determined.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim: To evaluate medium to late (visit 1: 6-12 months after hospital discharge) effects of&#xD;
      COVID-19 on lung function, exercise capacity, thoracic CT findings, symptoms and HRQoL in&#xD;
      patients with confirmed diagnosis of SARS-CoV-2 infection and the relation between these&#xD;
      parameters.&#xD;
&#xD;
      Material and methods: Prospective cohort of subjects with laboratory and/or thoracic CT&#xD;
      confirmed COVID-19 who were treated as inpatients. Participants will perform spirometry, lung&#xD;
      diffusion capacity of carbon monoxide, 6-minute walk test (6MWT) and cardiopulmonary exercise&#xD;
      testing (CPET) after 6-12 months (Visit 1) of COVID-19. Clinical, laboratory and chest image&#xD;
      data during the COVID-19 hospitalization will be obtained from medical records.&#xD;
&#xD;
      The minimum sample size was estimated as 37 participants.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">October 15, 2020</start_date>
  <completion_date type="Anticipated">March 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 15, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Forced vital capacity (FVC)</measure>
    <time_frame>at 6-12 months after discharge</time_frame>
    <description>in ml</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lung diffusion capacity for carbon monoxide (DLCO)</measure>
    <time_frame>at 6-12 months after discharge</time_frame>
    <description>DLCO (%predicted); DLCO/alveolar volume- DLCO/VA (%predicted)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>6-minute walk test distance</measure>
    <time_frame>at 6-12 months after discharge</time_frame>
    <description>m</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Short-form 36 questionnaire (SF-36)</measure>
    <time_frame>at 6-12 months after discharge</time_frame>
    <description>scores range between 0 and 100 with higher scores indicating a better HRQoL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxygen uptake at peak exercise</measure>
    <time_frame>at 6-12 months after discharge</time_frame>
    <description>from incremental Cardiopulmonary exercise test (% of predicted)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Minute-ventilation/carbon dioxide output during exercise</measure>
    <time_frame>at 6-12 months after discharge</time_frame>
    <description>from incremental Cardiopulmonary exercise test (L/L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Dyspnea during exercise</measure>
    <time_frame>at 6-12 months after discharge</time_frame>
    <description>from incremental Cardiopulmonary exercise test (measured with 10-point categorical Borg scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Thoracic CT findings</measure>
    <time_frame>in hospital and at 6-12 months after discharge</time_frame>
    <description>lung parenchymal abnormalities as percentage of occupied lung</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Forced expiratory volume in 1 second</measure>
    <time_frame>at 6-12 months after discharge</time_frame>
    <description>in ml and %predicted</description>
  </primary_outcome>
  <primary_outcome>
    <measure>FEV1/FVC ratio</measure>
    <time_frame>at 6-12 months after discharge</time_frame>
    <description>in %</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Forced vital capacity %predicted (FVC%)</measure>
    <time_frame>at 6-12 months after discharge</time_frame>
    <description>in %</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Signs and symptoms</measure>
    <time_frame>in hospital and at 6-12 months after discharge</time_frame>
    <description>Recorded separately as present or absent) mortality (recorded as present or absent)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to hospital discharge</measure>
    <time_frame>in hospital</time_frame>
    <description>in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU discharge</measure>
    <time_frame>in hospital</time_frame>
    <description>in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weaning from intubation</measure>
    <time_frame>in hospital</time_frame>
    <description>in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weaning from supplemental oxygen</measure>
    <time_frame>in hospital</time_frame>
    <description>in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weaning from noninvasive mechanical ventilation</measure>
    <time_frame>in hospital</time_frame>
    <description>in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>in hospital and at 6-12 months after discharge</time_frame>
    <description>recorded as present or absent</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">37</enrollment>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>COVID-19 inpatients</arm_group_label>
    <description>Patients with laboratory and/or thoracic CT confirmed COVID-19 pneumonia ; older than18 years of age; treated as inpatients; evaluated at 6-12 months after hospital discharge in outpatient clinic</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>spirometry, thoracic CT, CPET, 6 minute walking test, SF-36 questionnaire</intervention_name>
    <description>Participants will perform spirometry, lung diffusion capacity of carbon monoxide, 6-minute walk test (6MWT), Short form-36 (SF-36) questionnaire and cardiopulmonary exercise testing (CPET) after 6-12 months (Visit 1) of COVID-19. Clinical, laboratory and chest image data during the COVID-19 hospitalization will be obtained from medical records.</description>
    <arm_group_label>COVID-19 inpatients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults with Covid-19 diagnosis&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients with Covid 19 diagnosis&#xD;
&#xD;
          -  Ability to read and speak&#xD;
&#xD;
          -  Signed informed consent.&#xD;
&#xD;
          -  Able to perform exercise testing and walking&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Subjects with limited exercise capacity&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benan Çağlayan, Prof Dr</last_name>
    <role>Study Chair</role>
    <affiliation>Koç University Hospital Pulmonology Department</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Koç University Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34010</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 19, 2020</study_first_submitted>
  <study_first_submitted_qc>October 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 23, 2020</study_first_posted>
  <last_update_submitted>October 22, 2020</last_update_submitted>
  <last_update_submitted_qc>October 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Koc University Hospital</investigator_affiliation>
    <investigator_full_name>Fatma Işıl Uzel</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Covid19</keyword>
  <keyword>lung functions</keyword>
  <keyword>cardiopulmonary exercise testing</keyword>
  <keyword>thoracic CT</keyword>
  <keyword>6 minute walking test</keyword>
  <keyword>Short form 36 questionnaire</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

